23

Literatur

Eigene Artikel als Erstautor

E1 Koenig F, Jung K, Schnorr D, Loening SA. "Urinary markers of malignancy." Clin Chim Acta 2000, 297: 191-205

E2 Koenig F, McGovern FJ. "Fluorescence detection of bladder carcinoma." Urology 1997, 50: 778-779

E3 Koenig F, McGovern FJ, Larne R, Enquist H, Schomacker KT, Deutsch TF. "Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolevulinic acid. Brit " J Urol 1999, 83: 129-135

E4 Koenig F, McGovern FJ, Althausen AF, Deutsch TF, Schomacker KT. "Laser-induced autofluorescence diagnosis of bladder cancer. " J Urol 1996, 156: 1597-1601

E5 Koenig F, McGovern FJ, Enquist H, Larne R, Althausen AF, Deutsch TF, Schomacker KT. "Autofluorescence guided biopsies for early detection of bladder carcinoma. " J Urol 1998, 159: 1871-1875

E6 Koenig F, Larne R, Enquist H, McGovern FJ, Schomacker KT, Kollias N, Deutsch TF. "Spectroscopic measurement of diffuse reflectance for enhanced detection of bladder carcinoma. " Urology 1998, 51: 342-345

E7 Koenig F, Tearney GJ, Bouma BE. "Optical coherence tomography in urology. Chapter 28 in: Tearney GJ, Bouma BE, editors." Handbook of Optical Coherence Tomography. Marcel Dekker, Inc. 2001, pp 725-737

E8 König F, Loening SA. "Strategien in der bildgebenden Diagnostik des Harnblasenkarzinoms. " Urologe B 1999, 39 :303-306

E9 Koenig F, Gonzalez S, White WM, Lein M, Rajadhyaksha M. "Near-infrared confocal laser scanning microscopy of bladder tissue in vivo. " Urology 1999, 53: 853-857

E10 Koenig F, Knittel J, Schnieder L, George M, Lein M, Schnorr D. "Confocal laser scanning microscopy of the urinary bladder following intravesical instillation of a fluorescent dye. " Urology 2001 (submitted)

24

E11 Koenig F, Knittel J, Stepp H. "Diagnosing cancer in vivo." Science 2001, 292: 1401-1402

E12 Koenig F, Schomacker KT, McGovern FJ, Deutsch TF. United States Patent, Patent No: U.S. 6,289,236 B1 (date of patent: September 11th, 2001). "Methods and apparatus for distinguishing inflamed and tumorous bladder tissue."

Eigene Artikel als Koautor

K1 Gerhards S, Jung K, Koenig F, Daniltchenko D, Hauptmann S, Schnorr D, Loening SA. "Excretion of matrix metalloproteinases 2 and 9 in urine is associated with high stage and grade bladder carcinoma. " Urology 2001, 57: 675-679

K2 Gerhards S, Jung K, Koenig F, Daniltchenko D, Hauptmann S, Schnorr D, Loening SA. "Letter to the editor re: C.F.M. Sier et al., Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers. " Clin Cancer Res 2001, 7: 445-446

K3 Staak A, Koenig F, Daniltchenko D, Hauptmann S, Loening SA, Schnorr D, Jung K. Cathepsin B, "H and L activities in urine of patients with transitional cell carcinoma of the bladder. " Urology 2002, 59: 308-312

K4 Ebeling V, König F, Loening SA. "Biodristribution von 5-Aminolävulinsäure (ALA) induziertem Protoporphyrin IX (PPIX) in Zystektomiepräparaten. " Urologe A 1999; 38: S102 (Suppl.)

K5 Riedl CR, Daniltchenko D, Koenig F, Simak R, Loening SA, Pflüger H. "Fluorescence endoscopy with 5-aminolevulinic acid (ALA) reduces early recurrence rate in superficial bladder cancer. " J Urol 2001, 165: 1121-1123

25

Fremdliteratur

1 Kleiner DE, Stetler-Stevenson WG. "Matrix metalloproteinases and metastasis. " Cancer Chemother Pharmacol 1999, 43 Suppl: S42-S51

2 Zucker S, Lysik RM, DiMassimo BI, et al. "Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer. " Cancer 1995, 76: 700-708

3 Naylor MS, Stamp GW, Davies BD, et al. "Expression and activity of MMPS and their regulators in ovarian cancer. " Int J Cancer 1994, 58: 50-56

4 Forsyth PA, Wong H, Laing TD, et al. "Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. " Br J Cancer 1999, 79: 1828-1835

5 Margulies IM, Hoyhtya M, Evans C, et al. "Urinary type IV collagenase: elevated levels are associated with bladder transitional cell carcinoma. " Cancer Epidemiol Biomarkers 1992, Prev 1: 467-474

6 Özdemir E, Kakehi Y, Okuno H, et al. "Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas. " J Urol 1999, 161: 1359-1363

7 Hanemaaijer R, Sier CF, Visser H, et al. "MMP-9 activity in urine from patients with various tumors, as measured by a novel MMP activity assay using modified urokinase as a substrate. " Ann N Y Acad Sci 1999, 878: 141-149

8 Campo E, Munoz J, Miquel R, et al. "Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. " Am J Pathol 1994, 145: 301-309

9 Ebert W, Knoch H, Werle B, et al. "Prognostic value of increased lung tumor tissue cathepsin B. " Anticancer Res 1994, 14: 895-899

10 Friedrich B, Jung K, Lein M, et al. "Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue. " Eur J Cancer 1999, 35: 138-144

11 Jung K, Friedrich B, Turk I, et al: "Cathepsins B, H, L and cysteine proteinase inhibitors in renal cell carcinoma: no evidence for dysregulated proteolytic balance. " J Cancer Res Clin Oncol 124: 60-61, 1998

12 Ueda M. "A study on cathepsin B-like substance in cancer of the urinary tract. " Nippon Hinyokika Gakkai Zasshi 1995, 86: 1429-1434

13 Baumgartner R, Kriegmair M, Stepp HG, et al. "Photodynamic diagnosis following intravesical instillation of aminolevulinic acid (ALA): first clinical experiences in urology. " In Dougherty TJ editor, Optical methods for tumor treatment and detection, Mechanisms and techniques in photodynamic therapy II, Vol. 1881. Proc SPIE 1993: 20-25

26

14 Zaak D, Stepp H, Oberneder R, et al. "Endoscopic detection of transitional cell carcinoma with 5-Aminolevulinic acid - Results of 1012 fluorescence endoscopies. " Urology 2001, 57: 690-694

15 Tatematsu M, Cohen SM, Fukushima S, et al. "Neovascularization in benign and malignant urinary bladder epithelial proliferative lesions of the rat observed in situ by scanning electron microscopy and autoradiography. " Cancer Res 1978, 38: 1792-1800

16 Cohen SM, Tatematsu M, Shinohara Y, et al. "Neovascularization in rats during urinary bladder carcinogenesis induced by N-[4-(5-Nitro-2-furyl)-2-thiazolyl] formamide. " JNCI 1980, 65: 145-148

17 Lurie AG, Tatematsu M, Nakatsuka T, et al. "Anatomical and functional vascular changes in hamster cheek pouch during carcinogenesis induced by 7,12-Dimethylbenz(a)anthracene. " Cancer Res 1983, 43: 5986-5994

18 Jaeger TM, Weidner N, Karen C, et al. "Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. " J Urol 1995, 154: 69-71

19 Uchida K, Akaza H. "Intraluminal ultrasonography in urology; development of endoscopic ultrasonography using flexible miniature probe. " J Urol 1999, 161: 92 (Suppl.)

20 Tearney GJ, Brezinski ME, Southern JF, Bouma BE, Boppart SA, Fujimoto JG. "Optical biopsy in human urologic tissue using optical coherence tomography. " J Urol 1997, 157: 1915

21 Rajadhyaksha M, Grossman M, Esterowitz D, Webb RH, Anderson RR. "In vivo confocal scanning laser microscopy of human skin: melanin provides the strongest contrast. " J Invest Dermatol 1995, 104: 946

22 Knittel J, Schnieder L, Buess G, Messerschmidt B, and Possner T: "Endoscope-compatible confocal microscope using a gradient index-lens system. " Opt Com 2001, 188: 267-273

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.